Marshall Wace North America’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Marshall Wace North America's LLY Position: Q3 2021 in Review
Marshall Wace North America increased its Eli Lilly (LLY) stake by 428% in Q3 2021, buying an estimated $79.3M and bringing the position to 396,689 shares worth $91.7M. The position accounts for 0.39% of the portfolio, ranked #47.
Marshall Wace North America first reported a position in LLY in Q2 2013 and has held it in 14 quarters since. 2,052 funds tracked by Wall St. Rank hold LLY as of Q3 2021.
- Marshall Wace North America held 396,689 shares of Eli Lilly worth $91.7M as of Q3 2021.
- Marshall Wace North America bought 321,495 Eli Lilly shares in Q3 2021, an estimated $79.3M.
- Eli Lilly made up 0.39% of Marshall Wace North America's portfolio in Q3 2021, its #47 holding.
- Marshall Wace North America first reported a position in Eli Lilly in Q2 2013 and has held it in 14 quarters since.
- 2,052 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.